Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

358 ARTÍCULOS , VIENDO DEL 181 AL 195

Mild versus moderate stages of Alzheimer's disease: three-year outcomes in a routine clinical setting of cholinesterase inhibitor therapy

Wattmo C, Minthon L, Wallin ÅK.

Alzheimers Res Ther. 2016 Feb 17;8:7. doi: 10.1186/s13195-016-0174-1.

Editorial: Translational Alzheimer's Disease Research

Huang Y, Lahiri DK.

Curr Alzheimer Res. 2016;13(3):214. doi: 10.2174/156720501303160217102238.

Evaluation of a mobile team dedicated to behavioural disorders as recommended by the Alzheimer Cooperative Valuation in Europe joint action: observational cohort study

Krolak-Salmon P, Roubaud C, Finne-Soveri H, Riolacci-Dhoyen N, Richard G, Rouch I, Leperre-Desplanques A, Dauphinot V.

Eur J Neurol. 2016 May;23(5):979-88. doi: 10.1111/ene.12975. Epub 2016 Mar 6.

Two Phase 2 Multiple Ascending-Dose Studies of Vanutide Cridificar (ACC-001) and QS-21 Adjuvant in Mild-to-Moderate Alzheimer's Disease

Pasquier F, Sadowsky C, Holstein A, Leterme Gle P, Peng Y, Jackson N, Fox NC, Ketter N, Liu E, Ryan JM; ACC-001 (QS-21) Study Team.

J Alzheimers Dis. 2016;51(4):1131-43. doi: 10.3233/JAD-150376.

Efficacy and Safety of ABT-126 in Subjects with Mild-to-Moderate Alzheimer's Disease on Stable Doses of Acetylcholinesterase Inhibitors: A Randomized, Double-Blind, Placebo-Controlled Study

Florian H, Meier A, Gauthier S, Lipschitz S, Lin Y, Tang Q, Othman AA, Robieson WZ, Gault LM.

J Alzheimers Dis. 2016;51(4):1237-47. doi: 10.3233/JAD-150978.

Significant cognitive improvement with cholinesterase inhibition in AD with cerebral amyloid angiopathy

Paterson RW, Abdi Z, Haines A, Schott JM.

Clin Neurol Neurosurg. 2016 May;144:64-6. doi: 10.1016/j.clineuro.2016.02.036. Epub 2016 Mar 3.

Transcranial direct current stimulation as a memory enhancer in patients with Alzheimer's disease: a randomized, placebo-controlled trial

Bystad M, Grønli O, Rasmussen ID, Gundersen N, Nordvang L, Wang-Iversen H, Aslaksen PM.

Alzheimers Res Ther. 2016 Mar 23;8(1):13. doi: 10.1186/s13195-016-0180-3.

Rivastigmine Patch in Chinese Patients with Probable Alzheimer's disease: A 24-week, Randomized, Double-Blind Parallel-Group Study Comparing Rivastigmine Patch (9.5 mg/24 h) with Capsule (6 mg Twice Daily)

Zhang ZX, Hong Z, Wang YP, He L, Wang N, Zhao ZX, Zhao G, Shang L, Weisskopf M, Callegari F, Strohmaier C.

CNS Neurosci Ther. 2016 Jun;22(6):488-96. doi: 10.1111/cns.12521. Epub 2016 Mar 25.

Neuroimaging in Alzheimer's disease: preclinical challenges toward clinical efficacy

Dustin D, Hall BM, Annapragada A, Pautler RG.

Transl Res. 2016 Sep;175:37-53. doi: 10.1016/j.trsl.2016.03.005. Epub 2016 Mar 12.

Exercise as a pro-cognitive, pro-neurogenic and anti-inflammatory intervention in transgenic mouse models of Alzheimer's disease

Ryan SM, Kelly ÁM.

Ageing Res Rev. 2016 May;27:77-92. doi: 10.1016/j.arr.2016.03.007. Epub 2016 Mar 31.

Butyrylcholinesterase as a Diagnostic and Therapeutic Target for Alzheimer's Disease

Darvesh S.

Curr Alzheimer Res. 2016;13(10):1173-7. doi: 10.2174/1567205013666160404120542.

Alzheimer Disease

Apostolova LG.

Continuum (Minneap Minn). 2016 Apr;22(2 Dementia):419-34. doi: 10.1212/CON.0000000000000307.

Patient Management Problem

Finger EC.

Continuum (Minneap Minn). 2016 Apr;22(2 Dementia):674-8, 679-88. doi: 10.1212/CON.0000000000000314.

Exploring psychosocial interventions for people with dementia that enhance personhood and relate to legacy- an integrative review

Johnston B, Narayanasamy M.

BMC Geriatr. 2016 Apr 5;16:77. doi: 10.1186/s12877-016-0250-1.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias